Close
4

Seqens Seqens

X

Company profile for Kandy Therapeutics

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
KaNDy Therapeutics was spun out from NeRRe Therapeutics, itself a spin out from GSK, in 2017 at which time all data and intellectual property associated with NT-814 was transferred to KaNDy Therapeutics. NT-814 is a unique, first-in-class dual mechanism NK-1,3 antagonist therapy dosed orally once daily. It has the potential to be a true breakthrough non-hormonal alternative to hormone replacement therapy (HRT).

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Kandy Therapeutics
unitedkingdom_new Flag
Country
Country
United Kingdom
Address
Address
Stevenage Bioscience Catalyst Incubator Building Gunnels Wood Road, Stevenage, HERTS, SG1 2FX
Telephone
Telephone
+44 (0) 1438 906 960
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY